BNO
Click for more information
0.00% 1.0¢ bionomics limited

News: BNO Bionomics and EmpathBio to assess treatment combinations for PTSD

  1. Hot News
    191,623 Posts.
    lightbulb Created with Sketch. 2809
    clock Created with Sketch.
    18/02/21
    05:40
    Post #: 51099880

    Feb 17 (Reuters) - Biopharmaceutical firm Bionomics Ltd (BNO) said on Wednesday it signed an agreement with EmpathBio Inc, a unit of Germany's atai Life Sciences, to look at combining their drug treatments aimed at post-traumatic stress disorder (PTSD).

    The memorandum of understanding between Bionomics and EmpathBio will focus on using different combinations of their drug treatments to form a better treatment regimen for PTSD.

    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

HRZ Horizon firms up ore reserve for Boorara ahead of FY25 Q1 development decision
right-arrow Created with Sketch.
BGL Bellevue aims for 45% production increase by FY 2028, announces $150M placement
right-arrow Created with Sketch.
PEC Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil
right-arrow Created with Sketch.
NEWS Real estate dynamics & changes raise investor doubt
right-arrow Created with Sketch.
FMG Quarterly & half yearly reports: Drives Newmont up, Ampol flat, while Fortescue plunges 2.6%
right-arrow Created with Sketch.
NEWS Capital raisings wrap: Brainchip, Ovanti, Lake and VHM
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.